Atlantic BlueBio produces marine‑derived polysaccharides such as fucoidan, laminarin, and alginate from New England seaweed, delivering formulation‑ready, high‑purity ingredients that boost skin hydration, barrier support, and matrix protection.
Funding
Funding not disclosed
Founders
Product
Problem
Skincare formulators often lack sustainable, high‑performance bioactive ingredients that provide both strong hydration and matrix protection, leading to products with limited efficacy or reliance on synthetic additives.
Solution
Atlantic BlueBio develops marine‑derived polysaccharides—such as fucoidan, laminarin, and alginate—from New England‑grown seaweed to serve as bioactive, formulation‑ready ingredients for skincare. Their regional biorefinery platform ensures consistent extraction and scalability, delivering sulfated polysaccharides with proven matrix‑protective and hydrating properties. By providing these natural, high‑purity compounds, the company enables manufacturers to create more effective, eco‑friendly skincare products without extensive R&D on raw material sourcing.
Target Audience
Primary customers are skincare ingredient manufacturers and cosmetic formulators seeking natural, high‑performance actives for advanced moisturizers, anti‑aging, and barrier‑repair products.
Features
- Extraction of fucoidan, laminarin, and alginate using a standardized biorefinery process for batch‑to‑batch consistency
- Sulfated polysaccharide structures that enhance skin hydration, barrier support, and extracellular matrix protection
- Formulation‑ready powders or liquids designed for direct integration into creams, serums, and masks
- Domestic supply chain sourced from New England seaweed farms, reducing transport emissions and ensuring sustainability
- Scalable production capacity to meet commercial ingredient demand while maintaining bioactivity